Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nanovibronix Inc (NQ: NAOV )

1.020 USD +0.063 (+6.57%)
Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Nanovibronix Inc

< Previous 1 2 3 4 Next >
NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Regains Nasdaq Compliance
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it... 
From Business Wire News Releases
NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued... 
From Business Wire News Releases
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its... 
From Business Wire News Releases
NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Announces $6.0 Million Private Placement
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
Independent Study Finds Significant Benefits Provided by NanoVibronix’s UroShield® Device
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Expands Offerings with Introduction of PainShield Plus®
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today... 
From Business Wire News Releases
NanoVibronix Receives Positive Nasdaq Listing Determination
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From Business Wire News Releases
NanoVibronix Files U.S. Patent Application for PainShield® for Delivery of Cannabinoids for Alleviation of Chronic and Acute Pain
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, announces... 
From PR Newswire
NanoVibronix Increases Previously Announced Bought Deal to $1.8 Million
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix Announces $1.5 Million Bought Deal Offering
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix UroShield® Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
FDA Clears Path for Patient Access to UroShield Device for the duration of the Covid-19 pandemic; Significantly Expands Addressable Market during this time period 
From PR Newswire
NanoVibronix Announces Closing of $3.4 Million Bought Deal Offering and Partial Exercise of Underwriter's Option to Purchase Additional Shares
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix Increases Previously Announced Bought Deal to $3.25 Million
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix Announces $2.5 Million Bought Deal Offering
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix Announces First Shipments of new UroShield™ Devices
New Version of UroShield™ Proceeds with Plan for Submission for NICE Official Guidance 
From PR Newswire
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
Ultra Pain Products, Inc. to Distribute Products Throughout the United States 
From PR Newswire
NanoVibronix Fulfills its First Private Label Partnership with Medisana and Receives Award for PainShield PT 100 Quality
Nominated by Medisana and Honored with Prestigious Plus X Award 
From PR Newswire
NanoVibronix Expands License Agreement for UroShield® and PainShield™ with Existing Distributor to Include Canada and Turkey
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
From NewMediaWire
SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
From GlobeNewswire News Releases
NanoVibronix Announces License Agreement for WoundShield Product
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... 
From PR Newswire
NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™
Enables Providers to Prescribe PainShield to Help Individuals Manage Pain at Home, Avoiding Unnecessary Doctor Visits and Hospitalization During COVID-Related Stay-At-Home Proclamations 
From GlobeNewswire News Releases
NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis
Appealing to potential Regulatory agencies to increase use to reduce burden on the healthcare system 
From GlobeNewswire News Releases
NanoVibronix, Inc. to Present at the Investor Summit on December 17th in Philadelphia
From ACCESSWIRE
NanoVibronix to Present at Two Investor Conferences in December
LD Micro 12th Annual Main Event Investor Conference on December 11, 2019; Investor Summit on December 17, 2019 
From PR Newswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.